Mustang Stock Analysis

MBIO
 Stock
  

USD 0.59  0.02  3.28%   

The big decline in price over the last few months for Mustang Biomay encourage institutional investors to take a closer look at the firm as it is trading at a share price of 0.59 on 311,999 in trading volume. The company directors and management failed to add value to investors and position the firm supply of money to exploit market volatility in May. However, diversifying your holdings with Mustang Bio or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.68. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Mustang Bio partners.
Additionally, see Stocks Correlation.
  
Refresh
The Mustang Bio stock analysis report makes it easy to digest most publicly released information about Mustang Bio and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Mustang Stock analysis module also helps to analyze the Mustang Bio price relationship with some important fundamental indicators such as market cap and management efficiency.

Mustang Stock Analysis Notes

About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.46. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mustang Bio recorded a loss per share of 0.82. The entity had not issued any dividends in recent years. Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts. Mustang Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people. To find out more about Mustang Bio contact the company at 781 652-4500 or learn more at www.mustangbio.com.

Mustang Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Mustang Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Mustang Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Mustang Bio generated a negative expected return over the last 90 days
Mustang Bio has high historical volatility and very poor performance
Mustang Bio has some characteristics of a very speculative penny stock
Net Loss for the year was (66.37 M).
Mustang Bio currently holds about 109.62 M in cash with (53.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Mustang Bio has a frail financial position based on the latest SEC disclosures
Roughly 21.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.marketwatch.com: Mustang Bio Shares Rise 20 percent After Orphan Drug Status for MB-106 Lymphoma Treatment - MarketWatch

Mustang Bio Upcoming and Recent Events

Earnings reports are used by Mustang Bio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Mustang Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report23rd of March 2022
Next Financial Report13th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End23rd of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Mustang Largest EPS Surprises

Earnings surprises can significantly impact Mustang Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-05-12
2022-03-31-0.18-0.2-0.0211 
2021-11-12
2021-09-30-0.17-0.19-0.0211 
2021-05-14
2021-03-31-0.17-0.19-0.0211 
View All Earnings Estimates

Mustang Bio SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Mustang Bio prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Mustang Bio investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Mustang Bio specific information freely available to individual and institutional investors to make a timely investment decision.
24th of June 2022
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
31st of May 2022
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
View
12th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
22nd of April 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
23rd of March 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
17th of March 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
8th of March 2022
Financial Statements and Exhibits. Entry into a Material Definitive Agreement
View
4th of February 2022
Unclassified Corporate Event
View

Mustang Bio Thematic Classifications

In addition to having Mustang Bio stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products IdeaPharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Mustang Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 57.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mustang Bio's market, we take the total number of its shares issued and multiply it by Mustang Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Mustang Profitablity

Mustang Bio's profitability indicators refer to fundamental financial ratios that showcase Mustang Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Mustang Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Mustang Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Mustang Bio's profitability requires more research than a typical breakdown of Mustang Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.49) (0.52) 
Return on Average Equity(0.53) (0.57) 
Return on Invested Capital(10.47) (10.75) 

Management Efficiency

The entity has return on total asset (ROA) of (35.48) % which means that it has lost $35.48 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (62.96) %, meaning that it created substantial loss on money invested by shareholders. Mustang Bio management efficiency ratios could be used to measure how well mustang bio manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return on Average Assets is estimated to slide to -0.52. The value of Return on Average Equity is estimated to slide to -0.57. Mustang Bio Total Assets Per Share are quite stable at the moment as compared to the past year. The company's current value of Total Assets Per Share is estimated at 1.70. Net Current Assets as percentage of Total Assets is expected to rise to 89.32 this year, although the value of Total Assets will most likely fall to about 108.6 M.
Last ReportedProjected for 2022
Book Value per Share 1.28  1.41 
Enterprise Value over EBIT(1.00) (1.08) 
Enterprise Value over EBITDA(0.55) (0.60) 
Price to Book Value 1.38  1.95 
Tangible Assets Book Value per Share 1.42  1.60 
Enterprise Value35.3 M36.2 M
Tangible Asset Value125.2 M108.6 M

Technical Drivers

As of the 30th of June, Mustang Bio secures the mean deviation of 4.61, and Risk Adjusted Performance of (0.18). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mustang Bio, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Mustang Bio, which can be compared to its peers in the industry. Please verify Mustang Bio information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Mustang Bio is priced some-what accurately, providing market reflects its recent price of 0.59 per share. As Mustang Bio is a penny stock we also strongly advise to check its total risk alpha numbers.

Mustang Bio Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. Mustang Bio Triple Exponential Moving Average indicator shows smoothing effect of Mustang Bio price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
.

Mustang Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mustang Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mustang Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mustang Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Mustang Bio Predictive Daily Indicators

Mustang Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mustang Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Mustang Bio Forecast Models

Mustang Bio time-series forecasting models is one of many Mustang Bio's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mustang Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Mustang Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mustang Bio stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mustang shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Mustang Bio. By using and applying Mustang Stock analysis, traders can create a robust methodology for identifying Mustang entry and exit points for their positions.
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts. Mustang Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.

Current Mustang Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mustang analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mustang analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
9.8Strong Buy5Odds
Mustang Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Mustang analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mustang stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mustang Bio, talking to its executives and customers, or listening to Mustang conference calls.
Mustang Analyst Advice Details

Mustang Stock Analysis Indicators

Mustang Bio stock analysis indicators help investors evaluate how Mustang Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mustang Bio shares will generate the highest return on investment. By understating and applying Mustang Bio stock analysis, traders can identify Mustang Bio position entry and exit signals to maximize returns.
Quick Ratio10.14
Fifty Two Week Low0.5600
Shares Short Prior Month3.83M
Average Daily Volume Last 10 Day2.46M
Average Daily Volume In Three Month1.09M
Shares Percent Shares Out3.69%
Short Percent Of Float4.68%
Forward Price Earnings-0.68
Float Shares78.42M
Fifty Two Week High3.6150
Enterprise Value To Ebitda0.51
Fifty Day Average0.6990
Two Hundred Day Average1.4528
Additionally, see Stocks Correlation. Note that the Mustang Bio information on this page should be used as a complementary analysis to other Mustang Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Mustang Stock analysis

When running Mustang Bio price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
61.1 M
Return On Assets
-0.32
Return On Equity
-0.62
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Mustang Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.